Agata Machaczka

Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism

Jodi L. Smith, J. Witkin, P. Kawalec, 2022, Expert opinion on drug discovery.

Blunted type-5 metabotropic glutamate receptor-mediated polyphosphoinositide hydrolysis in two mouse models of monogenic autism

A. Arena, G. Battaglia, V. Bruno, 2023, Neuropharmacology.

Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies

B. Szewczyk, Agata Machaczka, Barbara Chruścicka-Smaga, 2023, Pharmacological Reports.